Ipsen Pharma s.r.o. is the Czech affiliate of the global biopharmaceutical group Ipsen, active in specialty care. The company focuses on the distribution, promotion and market support of Ipsen's therapies in oncology, rare diseases and neurosciences, as well as selected consumer healthcare products. Its Czech activities include medical promotion, market research, medical education, pharmacovigilance and support for access to innovative treatments. Ipsen's therapeutic portfolio addresses disorders such as oncological conditions, growth disorders, digestive system diseases and neurological disorders including conditions treated with botulinum toxin. Ipsen Pharma s.r.o. aligns with the group's global mission of improving patient outcomes through innovation, maintaining partnerships with clinicians and healthcare systems and operating within ethical and regulatory frameworks.
Headquarters
Olbrachtova 2006/9
Prague; The City of Prague;
Postal Code: 14000
Contact Details: Purchase the Ipsen Pharma S.R.O. report to view the information.
Website: https://www.ipsen.cz/
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service